Latest filing published 28 Apr 2017 for Teladoc Health, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -11.3%Entry US$133.68 · Close at T+365 US$118.56
- -18.7%Entry US$113.28 · Close at T+365 US$92.04
- -17.0%Entry US$116.40 · Close at T+365 US$96.60
- -8.9%Entry US$120.00 · Close at T+365 US$109.32
- +37.3%Entry US$105.00 · Close at T+365 US$144.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
CHP III LP: trading record in brief
Filings by CHP III LP span 2 companies, the busiest being Verastem, Inc. and Teladoc Health, Inc. In total, 16 filings cover trades dated from 27 January 2012 to 26 April 2017.
Market trades split into 8 purchases (€2.6M) and 2 sales (€7.7M). The net balance comes to €5.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €120k. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 83% of cases, with a median move of +39.0%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 28 April 2017 with a transaction in Teladoc Health, Inc. The clock since the last published purchase (13 June 2013) now reads 4,897 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to CHP III LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares0Common StockSEC:0000899243-17-011157:0
- 176,000 shares@ US$16.5935.7% of flowCommon StockSEC:0000899243-16-035579:0
- 324,000 shares@ US$16.2364.3% of flowCommon StockSEC:0000899243-16-035579:1
- 819,852 sharesCommon StockSEC:0001179110-15-011057:1
- 1,089,666 sharesCommon StockSEC:0001179110-15-011057:2
- 428,964 sharesCommon StockSEC:0001179110-15-011057:3
- 2,641,986 sharesCommon StockSEC:0001179110-15-011057:0
- 23,171 shares@ US$9.60Common StockSEC:0001072613-13-000281:1Canonical exit: 10 Sept 2013 (T+90)
- 25,000 shares@ US$9.74Common StockSEC:0001072613-13-000238:0Canonical exit: 11 Aug 2013 (T+90)
- 10,000 shares@ US$9.66Common StockSEC:0001072613-13-000214:0Canonical exit: 30 Jul 2013 (T+90)
- 5,631 shares@ US$9.50Common StockSEC:0001072613-13-000205:0Canonical exit: 16 Jul 2013 (T+90)
- 6,193 shares@ US$7.87Common StockSEC:0001072613-12-000715:0Canonical exit: 26 Apr 2012 (T+90)
- 1,984,126 sharesCommon StockSEC:0001072613-12-000039:0
- 250,000 shares@ US$10.00Common StockSEC:0001072613-12-000039:1Canonical exit: 26 Apr 2012 (T+90)
14 of 14 declarations
